Claire Mazumdar - CEO Eva Fortea - VP, Equity Research Ivan Hyep - CFO Lana Usmanova - Research Associate Rachel Frank - Senior Director and Head of Investor Relations and Corporate Communications Ryan Cohlhepp - President and COO Stephen Willey - Managing Director Tanya Green - Chief Development Officer Conference Call Participants Bicara Therapeutics (NasdaqGM:BCAX) Q4 2025 Earnings call March 30, 2026 08:30 AM ET Company Participants Eric Schmidt - Analyst Jeet Mukherjee - Biotechnology Analyst Judah Fro ...

Speaker4 Nano Labs 2025 Speaker6 Thank you, operator, and everyone for joining Nano Labs second half of 2025 earnings conference call today. On our call today, I will provide an overview of our recent development and our strategic initiatives going forward. Nano Labs (NasdaqCM:NA) H2 2025 Earnings call March 30, 2026 08:30 AM ET Speaker5 Thank you for standing by, and welcome to the Nano Labs Ltd Second Half 2025 Earnings Conference Call. All participants are in a listen-only mode. There will be a presentat ...

Rezolve AI (NasdaqGM:RZLV) Q4 2025 Earnings call March 30, 2026 08:30 AM ET Speaker5Good day and thank you for standing by. Welcome to the Rezolve AI second half and full year 2025 earnings conference call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be the question and answer session. To ask a question during the session, you need to press star one one on your telephone keypad. You will then hear an automatic message advising your hand is raised. To ...

PAVmed (NasdaqCM:PAVM) Q4 2025 Earnings call March 30, 2026 08:30 AM ET Speaker5Good morning, and welcome to PAVmed's fourth quarter 2025 business update conference call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Monday, March 30, 2026. I would now like to turn the conference over to Matt Ri ...

Bicara Therapeutics (NasdaqGM:BCAX) Q4 2025 Earnings call March 30, 2026 08:30 AM ET Speaker8Good day, and thank you for standing by. Welcome to the Bicara Therapeutics fourth quarter and full year 2025 earnings call. At this time, all participants are on a listen-only mode. After the speaker's presentation, there'll be a question-and-answer session. To ask a question during the session, you'll need to press star one one on your telephone. You will then hear an automated message advising your hand is raised ...

CBAK Energy Technology (NasdaqCM:CBAT) Q4 2025 Earnings call March 30, 2026 08:00 AM ET Company ParticipantsArina Tian - IR SpecialistCharles Nemek - ShareholderJiewei Li - CFOZhiguang Hu - CEONone - TranslatorConference Call ParticipantsBrian Lantier - Senior Research AnalystOperatorGood day, ladies and gentlemen. Thank you for standing by, and welcome to CBAK Energy Technology's fourth quarter and full year 2025 earnings conference call. Currently, all participants are in listen-only mode. Later, we will ...

CBAK Energy Technology (NasdaqCM:CBAT) Q4 2025 Earnings call March 30, 2026 08:00 AM ET Company ParticipantsArina Tian - IR SpecialistCharles Nemec - ShareholderJiewei Li - CFO and Company SecretaryZhiguang Hu - CEONone - TranslatorConference Call ParticipantsBrian Lantier - Senior Research AnalystOperatorGood day, ladies, and gentlemen. Thank you for standing by, and welcome to CBAK Energy Technology's fourth quarter and full year 2025 earnings conference call. Currently, all participants are in listen-onl ...

PDS Biotechnology (NasdaqCM:PDSB) Q4 2025 Earnings call March 30, 2026 08:00 AM ET Company ParticipantsFrank Bedu-Addo - CEOKirk Shepard - CMOLars Boesgaard - CFOMayank Mamtani - Senior Managing DirectorMike Moyer - Managing DirectorConference Call ParticipantsJosh Korsen - AnalystOperatorGreetings, and welcome to the PDS Biotechnology Q4 2025 Earnings Call. At this time, all participants are in listen-only mode. A question and answer session will follow the formal presentation. If anyone should require ope ...

PDS Biotechnology (NasdaqCM:PDSB) Q4 2025 Earnings call March 30, 2026 08:00 AM ET Company ParticipantsFrank Bedu-Addo - CEOKirk Shepard - CMOLars Boesgaard - CFOMayank Mamtani - Senior Managing DirectorMike Moyer - Managing DirectorConference Call ParticipantsJosh Korsen - AnalystOperatorGreetings, and welcome to the PDS Biotechnology fourth quarter 2025 earnings call. At this time, all participants are in listen-only mode. A question and answer session will follow the formal presentation. If anyone should ...

Neumora Therapeutics (NasdaqGS:NMRA) Q4 2025 Earnings call March 30, 2026 08:00 AM ET Company ParticipantsAlyssa Larios - Company RepresentativeBill Aurora - Chief Operating and Development OfficerBrian Abrahams - Global Managing Director and Sector Head of Healthcare ResearchDouglas Tsao - Managing Director of Equity ResearchHelen Rubinstein - VP of Investor Relations and Corporate StrategyJosh Pinto - PresidentJulian Pino - Biotechnology Equity Research Senior AssociateMike Milligan - CFONick Brandon - Ch ...